Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Quality Index
Zhejiang Hisun Pharmaceutical Co Ltd cash flow quality index. Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Cash Flow Quality Index of 2.71x as of September 2025. Operating cash flow of CN¥438.43 Million exceeds net income of CN¥161.86 Million, indicating high earnings quality where cash backs reported profits. See Zhejiang Hisun Pharmaceutical Co Ltd (600267) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Cash flow quality index of Zhejiang Hisun Pharmaceutical Co Ltd from 1999 to 2025. Historical Cash Flow Quality Index for Zhejiang Hisun Pharmaceutical Co Ltd across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 600267 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Zhejiang Hisun Pharmaceutical Co Ltd Cash Flow Quality Index by Year (1999–2025)
Zhejiang Hisun Pharmaceutical Co Ltd cash flow quality index by year from 1999 to 2025. Year-by-year earnings quality comparison for Zhejiang Hisun Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see how efficiently does Zhejiang Hisun Pharmaceutical Co Ltd generate cash.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 3.76x | CN¥2.03 Billion | CN¥540.71 Million | ▲ +5.1% |
| 2024 | 3.58x | CN¥2.11 Billion | CN¥591.31 Million | ▼ -14.9% |
| 2022 | 4.20x | CN¥2.07 Billion | CN¥491.42 Million | ▲ +23.6% |
| 2021 | 3.40x | CN¥1.74 Billion | CN¥510.63 Million | ▲ +54.7% |
| 2020 | 2.20x | CN¥1.59 Billion | CN¥723.17 Million | ▲ +1.7% |
| 2019 | 2.16x | CN¥698.39 Million | CN¥323.27 Million | ▼ -59.7% |
| 2017 | 5.36x | CN¥1.24 Billion | CN¥231.57 Million | ▼ -57.3% |
| 2016 | 12.54x | CN¥775.90 Million | CN¥61.85 Million | ▲ +115.2% |
| 2015 | 5.83x | CN¥736.17 Million | CN¥126.30 Million | ▲ +463.4% |
| 2014 | 1.03x | CN¥571.04 Million | CN¥551.97 Million | ▼ -0.4% |
| 2013 | 1.04x | CN¥527.25 Million | CN¥507.52 Million | ▼ -25.6% |
| 2012 | 1.40x | CN¥375.75 Million | CN¥269.05 Million | ▲ +37.0% |
| 2011 | 1.02x | CN¥525.31 Million | CN¥515.45 Million | ▼ -25.1% |
| 2010 | 1.36x | CN¥509.18 Million | CN¥374.35 Million | ▼ -19.8% |
| 2009 | 1.70x | CN¥472.85 Million | CN¥278.70 Million | ▲ +53.9% |
| 2008 | 1.10x | CN¥221.28 Million | CN¥200.69 Million | ▼ -64.0% |
| 2007 | 3.06x | CN¥437.72 Million | CN¥142.83 Million | ▲ +131.0% |
| 2006 | 1.33x | CN¥108.03 Million | CN¥81.43 Million | ▲ +38.7% |
| 2005 | 0.96x | CN¥113.53 Million | CN¥118.68 Million | ▼ -33.1% |
| 2004 | 1.43x | CN¥312.93 Million | CN¥218.79 Million | ▼ -13.7% |
| 2003 | 1.66x | CN¥288.45 Million | CN¥174.08 Million | ▼ -27.8% |
| 2002 | 2.30x | CN¥120.82 Million | CN¥52.63 Million | ▲ +63.0% |
| 2001 | 1.41x | CN¥69.14 Million | CN¥49.07 Million | ▲ +39.3% |
| 2000 | 1.01x | CN¥55.70 Million | CN¥55.09 Million | ▲ +55.3% |
| 1999 | 0.65x | CN¥32.64 Million | CN¥50.15 Million | — |